Linda Peckel

Death from acute stroke has dropped by as much as 55 percent, shows a population study published in BMJ.

Late-in-life weight gain or weight loss appears to be associated with an increased risk of dementia, shows a Korean study of 67,219 men and women between 60-79 years old.

A single course of treatment with teplizumab delayed the development of type 1 diabetes in at-risk teens and children, shows a study presented at the American Diabetes Association annual meeting earlier this month.

Diabetes complications in young adults with type 2 diabetes are occurring in unusually high rates, researchers reported at the American Diabetes Association annual meeting held earlier this month in San Francisco.

A high consumption of ultra-processed foods (i.e. almost any consumable food item, except fresh fruits and vegetables) is associated with an increased risk of cardiovascular disease and mortality, show two studies in BMJ.

MAASTRICHT, The Netherlands--The significant combined effect of bempedoic acid and ezetimibe on LDL-C in patients at high risk for CV events may suggest a new era of non-statin therapy. 

MAASTRICHT, The Netherlands-Study results suggest that clinical trials of novel treatments targeting Lp(a) will not be affected by subjects with CV disease receiving antiplatelet therapy.

In this study, among participants with smartphone-detected AF, 72% had experienced no symptoms. This technology-based screening approach could have legs.

The 5-year PRAGUE-12 study outcomes show that LAA ablation in cardiac surgery patients with a history of atrial fibrillation reduces stroke rate vs cardiac surgery alone.

SAN FRANCISCO--Study results reported at the 40th HRS Scientific Sessions showed at 1 year, more patients remained AF-free in the renal  denervation/catheter ablation group than in the group receiving catheter ablation alone (71.4% vs 57.8%). 

SAN FRANCISCO― Results of the TREAT-AF trial showed burden of AF was reduced by 85% at 6 months using transcutaneous electrical stimulation of the vagus nerve, vs a sham procedure; findings were showcased at the 40th HRS Scientific Sessions.

National experts point to key developments in rheumatology to watch in the coming year.

We asked rheumatology experts to share their biggest challenges-and how they manage them.